AlphaYouCA
Congress trade
Rep. Cindy Axne (D-IA) bought $1K-$15K of Johnson & Johnson (JNJ) stock
Cindy Axne, U.S. Representative (D-IA), disclosed a purchase of Johnson & Johnson (JNJ) stock worth $1K-$15K in a STOCK Act filing on Oct 8, 2021.
The trade happened on Dec 31, 2019, 647 days before it was made public.
JNJ has moved +75.5% since the trade date, from $145.87 to $256.03 (Oct 2, 2026 close).
- Traded
- Dec 31, 2019
- Disclosed
- Oct 8, 2021
- Filing delay
- 647 days
- Price since
- +75.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyAMT$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- SellFRFHF$1K-$15KOct 8, 2021
- SellFRFHF$1K-$15KOct 8, 2021
- SellITW$1K-$15KOct 8, 2021
- SellITW$1K-$15KOct 8, 2021
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.